Cypress, Calif. (October 4, 2017) – DiaSorin Molecular introduces two primer pairs – group C and group G Streptococcus – for use in laboratory-developed molecular tests. These new offerings join DiaSorin’s menu of more than 60 molecular reagents for bacterial, viral and fungal targets in addition to human genetic mutations.
The primer pairs are classified as analyte-specific reagents (ASRs), which can be used by high-complexity laboratories to develop their own lab-developed tests (LDTs). “These new primer pairs are the result of our ongoing work to develop and deliver a robust menu of molecular products,” said Michelle Tabb, vice president of research and development for DiaSorin Molecular. “With greater access to commercially developed molecular reagents, diagnostic labs are better able to customize tests that meet their unique patient needs.”
About DiaSorin Molecular
DiaSorin Molecular, LLC manufactures and distributes innovative molecular diagnostic products for hospital and reference laboratories. The company’s products help laboratories consolidate their testing, streamline processes and increase efficiency. DiaSorin Molecular’s Simplexa® molecular diagnostic kits run on the company’s versatile LIAISON® MDX platform. The company provides service and support solutions for its kits and instruments through a global network of offices and distributors. DiaSorin Molecular also markets a range of ASRs (analyte-specific reagents) for use in lab-developed tests.
